NAPTUMOMAB ESTAFENATOX
UNII 93T929W6LC

Substance Identification & Data

This profile provides standardized clinical and technical data for Naptumomab Estafenatox, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 93T929W6LC.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 676258-98-3 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

93T929W6LC

CAS Registry Number

676258-98-3

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

NAPTUMOMAB ESTAFENATOX

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C95789

National Cancer Institute reference terminology for clinical and research data.

INN ID

8598

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Naptumomab Estafenatox. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

NAPTUMOMAB ESTAFENATOX

Common Names & Synonyms

IMMUNOGLOBULIN, ANTI-(HUMAN TUMOR-ASSOCIATED ANTIGEN) (MOUSE MONOCLONAL 5T4 HEAVY CHAIN FRAGMENT) FUSION PROTEIN WITH SUPERANTIGEN SEA/E-120 (SYNTHETIC), COMPLEX WITH MOUSE MONOCLONAL 5T4 LIGHT CHAIN

NAPTUMOMAB ESTAFENATOX [INN]

NAPTUMOMAB ESTAFENATOX [MART.]

NAPTUMOMAB ESTAFENATOX [WHO-DD]

SUPERANTIGEN ABR-217620